Larry G Birkenmeyer

This inventor holds 18 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Monoclonal Antibodies. Top assignees: Abbott Laboratories Corporation, Abbvie Deutschland Gmbh and Co Kg, Abbvie Inc.. Active years: 1995-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Larry G Birkenmeyer. Retrieved from https://idiyas.com/inventor/larry-g-birkenmeyer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 2)

% Patents Active = 61.1

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 5.4

ph-index = 5

Forward Citations = 419(Granted Patents)

Location History:

Chicago, IL (US) (1995 - 2002)
Glenview, IL (US) (2011 - 2022)

Company Filing History:

17 out of 4,190

Abbott Laboratories Corporation

patents

1 out of 167

Abbvie Deutschland Gmbh and Co Kg

where one patent can have more than one assignee

Years Active: 1995-2022

Loading Chart...

Areas of Expertise:

Monoclonal Antibodies

HCV NS3 Antigens

Iron-Related Disorders

NGAL Binding Antibodies

Subtractive Hybridization

TT Virus Utilization

Hepatitis B Detection

Nucleic Acid Detection

Neisseria Gonorrhoeae

Ligase Chain Amplification

Antibody Detection

Primer Compositions

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11421023 - Anti-GP73 monoclonal antibodies and methods of obtaining the same (2022-08-23),

2. 10308709 - Anti-GP73 monoclonal antibodies and methods of obtaining the same (2019-06-04),

3. 9790478 - HCV NS3 recombinant antigens and mutants thereof for improved antibody detection (2017-10-17),

4. 9636398 - Composition and method for the diagnosis and treatment of iron-related disorders (2017-05-02),

5. 9469686 - Anti-GP73 monoclonal antibodies and methods of obtaining the same (2016-10-18),

6. 8846036 - Antibodies that bind to mammalian NGAL and uses thereof (2014-09-30),

7. 8318897 - [object Object] (2012-11-27),

8. 8283124 - [object Object] (2012-10-09),

9. 8268981 - [object Object] (2012-09-18),

10. 8063193 - [object Object] (2011-11-22),

11. 8030471 - [object Object] (2011-10-04),

12. 6455255 - Method of performing subtractive hybridization using RDA (2002-09-24),

13. 6395472 - Methods of utilizing the TT virus (2002-05-28),

14. 5955598 - Primer compositions and kits for detecting hepatitis B virus (1999-09-21),

15. 5807670 - Detection of hepatitis GB virus genotypes (1998-09-15),

Title: Unveiling Larry G Birkenmeyer: An Innovator in Glenview, IL

Introduction:

Larry G Birkenmeyer is a distinguished inventor hailing from Glenview, IL, with a remarkable portfolio of 18 patents to his name. His groundbreaking work in the field of biotechnology has left a lasting impact on the industry.

Latest Patents:

Among his latest patents is the invention of Anti-GP73 monoclonal antibodies and methods of obtaining the same. These antibodies revolutionize the detection of Golgi protein 73 (GP73) and fucosylated GP73 in samples, showcasing Birkenmeyer's commitment to advancing diagnostic technologies.

Career Highlights:

Larry G Birkenmeyer has made significant contributions to the field while working at renowned companies such as Abbott Laboratories and AbbVie Deutschland GmbH & Co. KG. His innovative spirit and dedication to research have been pivotal in driving forward advancements in the biotech sector.

Collaborations:

Throughout his career, Birkenmeyer has collaborated with exceptional professionals in the industry, including Suresh M Desai and Anthony Scott Muerhoff. Together, they have worked on cutting-edge projects that have pushed the boundaries of scientific innovation.

Conclusion:

In conclusion, Larry G Birkenmeyer stands as a trailblazer in the realm of biotechnology, with a rich tapestry of patents highlighting his ingenuity and expertise. His relentless pursuit of excellence continues to inspire future generations of inventors and researchers in the pursuit of innovation.

Profile summary based on public USPTO records.